SC
ZYNE
Sculptor Capital’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-82,100
| Closed | -$271K | – | 687 |
|
2020
Q4 | $271K | Hold |
82,100
| – | – | ﹤0.01% | 338 |
|
2020
Q3 | $272K | Hold |
82,100
| – | – | ﹤0.01% | 233 |
|
2020
Q2 | $277K | Buy |
82,100
+3,300
| +4% | +$11.1K | ﹤0.01% | 166 |
|
2020
Q1 | $302K | Sell |
78,800
-145,000
| -65% | -$556K | ﹤0.01% | 135 |
|
2019
Q4 | $1.35M | Hold |
223,800
| – | – | 0.01% | 141 |
|
2019
Q3 | $1.69M | Buy |
223,800
+134,100
| +149% | +$1.01M | 0.02% | 138 |
|
2019
Q2 | $1.22M | Hold |
89,700
| – | – | 0.01% | 150 |
|
2019
Q1 | $486K | Buy |
+89,700
| New | +$486K | ﹤0.01% | 129 |
|
2018
Q4 | – | Sell |
-16,300
| Closed | -$133K | – | 200 |
|
2018
Q3 | $133K | Hold |
16,300
| – | – | ﹤0.01% | 157 |
|
2018
Q2 | $159K | Buy |
+16,300
| New | +$159K | ﹤0.01% | 160 |
|
2017
Q4 | – | Sell |
-19,200
| Closed | -$161K | – | 131 |
|
2017
Q3 | $161K | Buy |
+19,200
| New | +$161K | ﹤0.01% | 182 |
|
2017
Q2 | – | Sell |
-9,600
| Closed | -$193K | – | 277 |
|
2017
Q1 | $193K | Buy |
+9,600
| New | +$193K | ﹤0.01% | 169 |
|